← FDA DRUG APPROVALS

FDA ANDA · ANDA074761

KETOROLAC TROMETHAMINE

Sponsor: MYLAN

APPLICATION
ANDA074761
TYPE
ANDA
ORIGINAL APPROVAL
1997-05-16
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

KETOROLAC TROMETHAMINEPrescription
KETOROLAC TROMETHAMINE 10MG · TABLET · ORAL

Approval history

2024-11-21Labeling · Supplement 22 · standardAP
2021-04-28Labeling · Supplement 15 · standardAP
2016-05-09Labeling · Supplement 12 · standardAP
2015-06-29Labeling · Supplement 9 · standardAP
2012-08-20Labeling · Supplement 8AP
2000-06-12Manufacturing (CMC) · Supplement 2AP
1998-01-29Manufacturing (CMC) · Supplement 1AP
1997-05-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →